Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Author index

Page Path
HOME > Browse > Author index
Search
Kwang-il Kim 1 Article
Pathophysiology
Article image
Blood Pressure Target in Type 2 Diabetes Mellitus
Hyun-Jin Kim, Kwang-il Kim, on Behalf of the Policy Committee of Korean Society of Hypertension
Diabetes Metab J. 2022;46(5):667-674.   Published online September 19, 2022
DOI: https://doi.org/10.4093/dmj.2022.0215
  • 8,394 View
  • 563 Download
  • 8 Web of Science
  • 15 Crossref
AbstractAbstract PDFPubReader   ePub   
The prevalence of diabetes mellitus continues to increase worldwide, and it is a well-established cardiovascular risk factor. Hypertension is also an important cardiovascular risk factor to be controlled and is common among patients with diabetes mellitus. Optimal blood pressure (BP) goals have been the subject of great debate in the management of hypertension among patients with diabetes mellitus. This review provides detailed results from randomized controlled trials and meta-analyses of clinical outcomes according to the target BP in patients with type 2 diabetes mellitus. In addition, the target BP in patients with diabetes mellitus recommended by different guidelines was summarized and presented. A target BP of <140/90 mm Hg is recommended for patients with hypertension and diabetes mellitus, and BP should be controlled to <130/80 mm Hg in patients with diabetes mellitus who have high-risk clinical features. We hope that this review will be helpful to clinicians and patients by promoting the understanding and appropriate application of BP control in the comprehensive management of patients with diabetes mellitus.

Citations

Citations to this article as recorded by  
  • Recent evidence on target blood pressure in patients with hypertension
    Hack-Lyoung Kim
    Cardiovascular Prevention and Pharmacotherapy.2024;[Epub]     CrossRef
  • Using Generative AI to Improve the Performance and Interpretability of Rule-Based Diagnosis of Type 2 Diabetes Mellitus
    Leon Kopitar, Iztok Fister, Gregor Stiglic
    Information.2024; 15(3): 162.     CrossRef
  • Additive interaction of family medical history of diabetes with hypertension on the diagnosis of diabetes among older adults in India: longitudinal ageing study in India
    Waquar Ahmed
    BMC Public Health.2024;[Epub]     CrossRef
  • Risk factors of undiagnosed and uncontrolled hypertension in primary care patients with hypertension: a cross-sectional study
    Emmanuel Adediran, Robert Owens, Elena Gardner, Andrew Curtin, John Stuligross, Danielle Forbes, Jing Wang, Dominik Ose
    BMC Primary Care.2024;[Epub]     CrossRef
  • Interplay of Adiponectin With Glycemic and Metabolic Risk Metrics in Patients With Diabetes
    Ritu Tiwari, Nishtha Singh, Shraddha Singh, Manish Bajpai, Shivam Verma
    Cureus.2024;[Epub]     CrossRef
  • Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care – The countrywide cross‐sectional AUSTRO‐PROFIT study
    Harald Sourij, Kehkishan Azhar, Faisal Aziz, Harald Kojzar, Caren Sourij, Peter Fasching, Martin Clodi, Bernhard Ludvik, Julia K. Mader, Michael Resl, Gersina Rega‐Kaun, Claudia Ress, Lars Stechemesser, Harald Stingl, Norbert J. Tripolt, Thomas Wascher, S
    Diabetes, Obesity and Metabolism.2024;[Epub]     CrossRef
  • Clinical and Sociodemographic Profile, Self-Care, Adherence and Motivation for Treatment, and Satisfaction with Social Support in Portuguese Patients with Type 2 Diabetes
    Virginia M. G. Regufe, Manuel A. Lobão, Natália Cruz-Martins, Carla Luís, Pedro von Hafe, Cristina B. Pinto
    Journal of Clinical Medicine.2024; 13(21): 6423.     CrossRef
  • Effectiveness of King’s Theory of Goal Attainment in Blood Glucose Management for Newly Diagnosed Patients With Type 2 Diabetes: Randomized Controlled Trial
    Man Yan, Yingchun Yu, Shuping Li, Peiling Zhang, Jiaxiang Yu
    Journal of Medical Internet Research.2024; 26: e59142.     CrossRef
  • Natural polysaccharides: The potential biomacromolecules for treating diabetes and its complications via AGEs-RAGE-oxidative stress axis
    Jie Sun, Na Wei, Chenxi Yu, Chao Li, Wei Li, Xiuyan Sun, Yanqing Zhang, Yaxin Li, Junbo Xie
    International Immunopharmacology.2024; 143: 113426.     CrossRef
  • Emerging roles of interferon-stimulated gene-15 in age-related telomere attrition, the DNA damage response, and cardiovascular disease
    María González-Amor, Beatriz Dorado, Vicente Andrés
    Frontiers in Cell and Developmental Biology.2023;[Epub]     CrossRef
  • Effects of Diabetes and Voluntary Exercise on IgA Concentration and Polymeric Immunoglobulin Receptor Expression in the Submandibular Gland of Rats
    Jaebum Park, Yuko Yamamoto, Kouki Hidaka, Satoko Wada-Takahashi, Shun-suke Takahashi, Toshiya Morozumi, Nobuhisa Kubota, Makiko Saita, Juri Saruta, Wakako Sakaguchi, Masahiro To, Tomoko Shimizu, Yuko Mikuni-Takagaki, Keiichi Tsukinoki
    Medicina.2023; 59(4): 789.     CrossRef
  • A diabetes update
    Zachary Bloomgarden
    Journal of Diabetes.2023; 15(7): 542.     CrossRef
  • CARDIOPROTECTIVE AND METABOLIC EFFECTS OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH SUCH COMORBIDITIES AS ARTERIAL HYPERTENSION, TYPE 2 DIABETES MELLITUS, AND OBESITY
    I. P. Dunaieva, N. O. Kravchun, І. A. Ilchenko
    Bulletin of Problems Biology and Medicine.2023; 1(2): 211.     CrossRef
  • Hypertensive Heart Failure
    Filippos Triposkiadis, Pantelis Sarafidis, Alexandros Briasoulis, Dimitrios E. Magouliotis, Thanos Athanasiou, John Skoularigis, Andrew Xanthopoulos
    Journal of Clinical Medicine.2023; 12(15): 5090.     CrossRef
  • 2023 Clinical Practice Guidelines for Diabetes
    Min Kyong Moon
    The Journal of Korean Diabetes.2023; 24(3): 120.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP